NNC0165-1562
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NNC0165-1562, covering 2018-07-13 to 2018-07-13. Get the full timeline:
Most recent: Clinical Trial Update: A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects [Phase 1]